RHYTHM PHARMACEUTICALS, INC.
RYTM
38 insider filings · Latest: Aug 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Aug 14 11:04 PM | Jennifer Kayden LeeEVP, Head of North America | Sale | 75,834 | $117.38 | $8.9M | 0(D) | View → |
| Aug 12, 2026 | Aug 14 11:01 PM | Yann MazabraudEVP, Head of International | Sale | 57,000 | $116.15 | $6.6M | 55,655(D) | View → |
| Aug 13, 2026 | Aug 13 8:51 PM | ALASTAIR GARFIELD | Proposed Sale | 7,763 | $117.60 | $912.9K | — | View → |
| Aug 13, 2026 | Aug 13 8:40 PM | JOSEPH J SHULMAN | Proposed Sale | 5,079 | $117.60 | $597.3K | — | View → |
| Aug 13, 2026 | Aug 13 8:39 PM | Jennifer Kayden Lee | Proposed Sale | 75,834 | $117.60 | $8.9M | — | View → |
| Aug 12, 2026 | Aug 12 8:34 PM | YANN MAZABRAUD | Proposed Sale | 57,000 | $112.85 | $6.4M | — | View → |
| Aug 11, 2026 | Aug 11 8:30 PM | PAMELA CRAMER | Proposed Sale | 11,406 | $115.48 | $1.3M | — | View → |
| Aug 10, 2026 | Aug 10 8:33 PM | PAMELA CRAMER | Proposed Sale | 3,520 | $115.63 | $407.0K | — | View → |
| Jun 22, 2026 | Jun 24 8:15 PM | Lynn A. TetraultDirector | Sale | 37,000 | $100.32 | $3.7M | 7,000(D) | View → |
| Jun 22, 2026 | Jun 22 8:49 PM | LYNN TETRAULT | Proposed Sale | 37,000 | $96.79 | $3.6M | — | View → |
| May 15, 2026 | May 19 8:15 PM | Christopher Paul GermanCorporate Controller & CAO | Sale | 4,643 | $92.21 | $428.1K | 0(D) | View → |
| Mar 4, 2026 | Mar 6 9:51 PM | Christopher Paul GermanCorporate Controller & CAO | Sale | 5,614 | $89.56 | $502.8K | 160(D) | View → |
| Mar 4, 2026 | Mar 4 9:14 PM | CAMILLE L BEDROSIAN | Proposed Sale | 64,540 | $90.62 | $5.8M | — | View → |
| Mar 3, 2026 | Mar 3 9:05 PM | CAMILLE L BEDROSIAN | Proposed Sale | 35,460 | $90.52 | $3.2M | — | View → |
| Feb 19, 2026 | Feb 20 2:02 AM | Hunter C SmithChief Financial Officer | Sale | 4,385 | $101.26 | $444.0K | 110,512(D) | View → |
| Feb 17, 2026 | Feb 20 2:02 AM | Hunter C SmithChief Financial Officer | Sale | 3,569 | $101.38 | $361.8K | 114,897(D) | View → |
| Feb 12, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 1,592 | $98.23 | $156.4K | 118,466(D) | View → |
| Feb 11, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 2,766 | $98.61 | $272.8K | 120,058(D) | View → |
| Feb 10, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Sale | 2,713 | $103.00 | $279.4K | 122,824(D) | View → |
| Feb 5, 2026 | Feb 6 11:38 PM | Hunter C SmithChief Financial Officer | Sale | 3,381 | $106.06 | $358.6K | 125,537(D) | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | Mar 4 12:45 AM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 1,162 | — | 1,162(D) | View → |
| Mar 2, 2026 | Mar 3 1:56 AM | Hunter C SmithChief Financial Officer | Option Exercise | 6,099 | $6.80 | 91,401(D) | View → |
| Feb 14, 2026 | Feb 18 9:30 PM | Yann MazabraudEVP, Head of International | Option Exercise | 10,000 | — | 30,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:53 PM | Joseph ShulmanChief Technical Officer | Grant/Award | 37,500 | $98.47 | 22,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:52 PM | David P MeekerDirector, President and CEO | Grant/Award | 179,750 | $98.47 | 107,850(D) | View → |
| Feb 11, 2026 | Feb 13 10:50 PM | Yann MazabraudEVP, Head of International | Grant/Award | 23,350 | — | 23,350(D) | View → |
| Feb 11, 2026 | Feb 13 10:49 PM | Jennifer Kayden LeeEVP, Head of North America | Grant/Award | 54,150 | $98.47 | 32,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:48 PM | Christopher Paul GermanCorporate Controller & CAO | Grant/Award | 5,215 | — | 5,215(D) | View → |
| Feb 11, 2026 | Feb 13 10:47 PM | Alastair GarfieldChief Scientific Officer | Grant/Award | 41,650 | $98.47 | 25,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:45 PM | Pamela J. CramerChief Human Resources Officer | Grant/Award | 29,150 | $98.47 | 17,500(D) | View → |
| Feb 11, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Grant/Award | 62,500 | $98.47 | 37,500(D) | View → |
| Feb 1, 2026 | Feb 3 9:38 PM | Yann MazabraudEVP, Head of International | Option Exercise | 5,500 | — | 11,000(D) | View → |
| Feb 1, 2026 | Feb 3 9:36 PM | Hunter C SmithChief Financial Officer | Option Exercise | 26,000 | — | 31,237(D) | View → |
| Feb 1, 2026 | Feb 3 9:35 PM | Joseph ShulmanChief Technical Officer | Option Exercise | 16,968 | — | 18,750(D) | View → |
| Feb 1, 2026 | Feb 3 9:34 PM | David P MeekerDirector, President and CEO | Option Exercise | 68,713 | — | 100,012(D) | View → |
| Feb 1, 2026 | Feb 3 9:33 PM | Jennifer Kayden LeeEVP, Head of North America | Option Exercise | 22,612 | — | 27,487(D) | View → |
| Feb 1, 2026 | Feb 3 9:32 PM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 3,613 | — | 5,418(D) | View → |
| Feb 1, 2026 | Feb 3 9:31 PM | Alastair GarfieldChief Scientific Officer | Option Exercise | 6,663 | — | 19,987(D) | View → |
| Feb 1, 2026 | Feb 3 9:30 PM | Pamela J. CramerChief Human Resources Officer | Option Exercise | 13,293 | — | 15,000(D) | View → |
← Previous
Page 2 of 2